Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine for Myocardial Protection During Cardiopulmonary Bypass
NCT07426237Phase 4Not yet recruiting
- Sponsor
- Hospital Nossa Senhora da Conceição
- Start
- Mar 2026
- Primary completion
- Jul 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of adenosine in myocardial reperfusion injury, sponsored by Hospital Nossa Senhora da Conceição. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
adenosine
03
Conditions
myocardial reperfusion injury
Beyond the preview
Go deeper on NCT07426237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07426237.